These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22409544)

  • 21. Finding key impurities in different manufacturing routes of a drug substance using liquid chromatography/mass spectrometry followed by principal components analysis.
    Carrier D; Eckers C; Arnoult T; Thurston T; Major H
    Rapid Commun Mass Spectrom; 2007; 21(23):3946-8. PubMed ID: 17975854
    [No Abstract]   [Full Text] [Related]  

  • 22. Application of high-resolution MS for development of peptide and large-molecule drug candidates.
    Kellie JF; Kehler JR; Szapacs ME
    Bioanalysis; 2016 Feb; 8(3):169-77. PubMed ID: 26795399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Automated optimization of mass spectrometric parameters in 'Tune' mode for impure analytes in dirty samples using gradient high-performance liquid chromatography.
    Rogatsky E; Stein D
    Rapid Commun Mass Spectrom; 2005; 19(24):3759-60. PubMed ID: 16308844
    [No Abstract]   [Full Text] [Related]  

  • 24. Metabolite structure analysis by high-resolution MS: supporting drug-development studies.
    Wagner DS; Pirhalla JL; Bowers GD
    Bioanalysis; 2013 Feb; 5(4):463-79. PubMed ID: 23414379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted quantitative bioanalysis in plasma using liquid chromatography/high-resolution accurate mass spectrometry: an evaluation of global selectivity as a function of mass resolving power and extraction window, with comparison of centroid and profile modes.
    Xia YQ; Lau J; Olah T; Jemal M
    Rapid Commun Mass Spectrom; 2011 Oct; 25(19):2863-78. PubMed ID: 21913265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LC-SPE-NMR-MS: a total analysis system for bioanalysis.
    Schlotterbeck G; Ceccarelli SM
    Bioanalysis; 2009 Jun; 1(3):549-59. PubMed ID: 21083152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ternary-column system for high-throughput direct-injection bioanalysis by liquid chromatography/tandem mass spectrometry.
    Xia YQ; Whigan DB; Powell ML; Jemal M
    Rapid Commun Mass Spectrom; 2000; 14(2):105-11. PubMed ID: 10623938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced resolution triple-quadrupole mass spectrometry for fast quantitative bioanalysis using liquid chromatography/tandem mass spectrometry: investigations of parameters that affect ruggedness.
    Jemal M; Ouyang Z
    Rapid Commun Mass Spectrom; 2003; 17(1):24-38. PubMed ID: 12478552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays.
    Chovan LE; Black-Schaefer C; Dandliker PJ; Lau YY
    Rapid Commun Mass Spectrom; 2004; 18(24):3105-12. PubMed ID: 15565734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of chemistry for the future of the pharma industry.
    Wild H; Heimbach D; Huwe C
    Angew Chem Int Ed Engl; 2011 Aug; 50(33):7452-3. PubMed ID: 21818828
    [No Abstract]   [Full Text] [Related]  

  • 31. Bioimaging of elements and small molecules using MS.
    Lockyer NP
    Bioanalysis; 2011 May; 3(10):1047-51. PubMed ID: 21585296
    [No Abstract]   [Full Text] [Related]  

  • 32. Mass spectrometry for small molecule pharmaceutical product development: a review.
    Gillespie TA; Winger BE
    Mass Spectrom Rev; 2011; 30(3):479-90. PubMed ID: 21500245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioanalysis without sample cleanup or chromatography: the evaluation and initial implementation of direct analysis in real time ionization mass spectrometry for the quantification of drugs in biological matrixes.
    Yu S; Crawford E; Tice J; Musselman B; Wu JT
    Anal Chem; 2009 Jan; 81(1):193-202. PubMed ID: 19117450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chemical drug development].
    Castro B
    Ann Pharm Fr; 2002 May; 60(3):147-9. PubMed ID: 12050592
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Building an empirical mass spectra library for screening of organic pollutants by ultra-high-pressure liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry.
    Díaz R; Ibáñez M; Sancho JV; Hernández F
    Rapid Commun Mass Spectrom; 2011 Jan; 25(2):355-69. PubMed ID: 21192031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ion mobility spectrometry: a comprehensive and versatile tool for occupational pharmaceutical exposure assessment.
    Armenta S; Blanco M
    Anal Chem; 2012 May; 84(10):4560-8. PubMed ID: 22500648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New active agents. The composition of commercial pharmaceutical specialties in 2001].
    Bernard M
    J Pharm Belg; 2002; 57(1):1-13. PubMed ID: 11913094
    [No Abstract]   [Full Text] [Related]  

  • 39. An accurate-mass-based spectral-averaging isotope-pattern-filtering algorithm for extraction of drug metabolites possessing a distinct isotope pattern from LC-MS data.
    Zhu P; Tong W; Alton K; Chowdhury S
    Anal Chem; 2009 Jul; 81(14):5910-7. PubMed ID: 19518135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supercritical fluid chromatography in research laboratories: design, development and implementation of an efficient generic screening for exploiting this technique in the achiral environment.
    de la Puente ML; López Soto-Yarritu P; Burnett J
    J Chromatogr A; 2011 Nov; 1218(47):8551-60. PubMed ID: 22018480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.